Collaboration deepens pipeline with CAAR design and optimization effort in three additional B cell-mediated autoimmune diseasesPHILADELPHIA, May 28, 2020 (GLOBE […]
CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel […]